Thanks to a $6.7 million grant, the newly named UCSF-Stanford Pediatric Device Consortium can focus on the development of revolutionary, low-cost gadgets to diagnose and cure pediatric health conditions.
The already famous CRISPR system allows scientists to edit faulty genes by cutting and replacing sections of DNA, but new and improved CRISPR techniques developed at UCSF have expanded CRISPR’s scalpel into a Swiss Army knife.
The journey from discovering and developing effective, precise medications to using them correctly and safely in patients is hardly fast and easy. Nor is it a straight shot. Scientists in the UCSF School of Pharmacy are challenging the status quo every step of the way.